Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Sirnaomics Ltd. ( (HK:2257) ) is now available.
Sirnaomics Ltd. has announced significant changes in its board of directors, including the resignation of Ms. Monin Ung as an independent non-executive director and the appointment of Dr. Yin Huijun as a non-executive director. These changes reflect a strategic shift in the company’s leadership, potentially impacting its governance and operational focus. Dr. Yin’s extensive experience in the biotechnology sector is expected to contribute to the company’s growth and strengthen its position in the industry.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics. The company is involved in creating innovative treatments for various medical conditions, leveraging its expertise in RNA interference technology.
Average Trading Volume: 802,754
Technical Sentiment Signal: Buy
Current Market Cap: HK$971.7M
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.